LG Innotek (011070) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Jun, 2026Executive summary
Revenue for Q1 2026 was KRW 5,534.8 billion, up 11.1% year-over-year, with operating income of KRW 295.3 billion and net income of KRW 229.1 billion, reflecting strong performance in optics and package solutions.
Gross margin improved to 10.1% from 7.5% year-over-year, driven by higher sales in premium camera modules and increased demand for semiconductor substrates.
The company maintained a robust financial position with total assets of KRW 11,822.1 billion and a debt-to-equity ratio of 0.94.
Financial highlights
Q1 2026 revenue: KRW 5,534.8 billion (+11.1% YoY); operating income: KRW 295.3 billion (+136% YoY); net income: KRW 229.1 billion (+167.8% YoY).
Gross profit: KRW 557.4 billion; gross margin: 10.1% (vs. 7.5% YoY).
Basic and diluted EPS: KRW 9,683 (vs. KRW 3,618 YoY).
Cash and cash equivalents at period end: KRW 1,372.6 billion.
Outlook and guidance
The company targets continued growth in premium camera modules, AI-driven semiconductor substrates, and automotive electronics.
Dividend payout ratio is set to increase to 15% by 2027 and 20% by 2030, supporting shareholder returns.
Ongoing investments in capacity expansion and R&D for next-generation products are planned.
Latest events from LG Innotek
- Revenue and profit fell significantly, but liquidity and R&D investment remained strong.011070
Q3 202524 Jun 2026 - Q1 2025 saw lower revenue and profit, but strong segment leadership and ongoing investment.011070
Q1 202524 Jun 2026 - H1 2025 revenue reached ₩8.9T, with net income of ₩76.9B and improved debt-to-equity ratio.011070
Q2 202524 Jun 2026 - Revenue up 3.3% to ₩21.9T, net income down 24% to ₩341.3B, all segments profitable.011070
Q4 202529 Mar 2026 - Revenue up 3% YoY, operating profit down 15%, strong liquidity and lower debt.011070
Q4 202417 Feb 2026 - H1 2024 revenue reached ₩8.89T, with net income of ₩237.4B and strong segment performance.011070
Q2 202417 Feb 2026 - Q3 revenue and profit declined sharply year-over-year, but core business and R&D investment remain strong.011070
Q3 202417 Feb 2026